We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Give a monthly donation to help us stay one step ahead of cancer with new smarter and targeted treatments – so that more people will survive blood cancer. Cecelia Brunott (pictured above) was ...

We discovered the function of the thymus and made key findings on the function of the two main subsets of lymphocytes, T cells and B cells. This was the fundamental basis for modern immunology.

We will unravel cancer’s ecosystem, overcome its evolution and drug resistance, and advance diagnosis and treatment – through world-class fundamental, translational and clinical research. The ICR and ...

The Institute of Cancer Research is committed to the professional development of its staff. In addition to the training and support provided within individual teams, the Learning and Development Team ...

The Taught Course in Oncology is a day-release modular programme designed for medically qualified candidates who intend to pursue a professional career in some aspect of clinical or medical oncology, ...

The ICR takes part in a range of public events, including local science festivals, events at museums and community events where we share knowledge and ideas about our research with the public. We ...

The Institute of Cancer Research has welcomed new plans to deliver around one million square feet of state-of-the-art research and laboratory space for life-sciences companies in Sutton, south London, ...

The Institute of Cancer Research, London, is a leading academic research centre in the UK and has achieved many awards that recognise the excellence of our teaching and research. We came second in the ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Here at The Institute of Cancer Research, we are a powerhouse of drug discovery. Since 2005, 13 of our drugs have entered clinical trials, and many more current cancer medicines are rooted in ...

We played a major role in characterising the BRAF gene and its role in cancer, increasing our understanding of malignant melanoma. Our work on the gene and the structure of the BRAF protein ...